Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Immuneering Corporation - Class A Common Stock
(NQ:
IMRX
)
6.040
-0.090 (-1.47%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 24, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Immuneering Corporation - Class A Common Stock
< Previous
1
2
3
4
5
6
7
8
Next >
Biotech/Oncology Stocks Targeting the Pancreatic Cancer Market – A Race Worth
March 06, 2024
EQNX::TICKER_START (ONASDAQ:ONCY),(TSX:ONC),(NASDAQ:BLRX),(NASDAQ:IMRX),(NASDAQ:CADL) EQNX::TICKER_END
Via
FinancialNewsMedia
Immuneering to Present Preclinical Data on Universal-RAS Program IMM-1-104 at American Association for Cancer Research Annual Meeting 2024
March 05, 2024
From
Immuneering Corporation
Via
GlobeNewswire
Immuneering to Participate in the Cowen 44th Annual Health Care Conference
March 04, 2024
From
Immuneering Corporation
Via
GlobeNewswire
4 Analysts Have This to Say About Immuneering
↗
August 08, 2023
Via
Benzinga
Expert Ratings for Immuneering
↗
June 26, 2023
Via
Benzinga
Analyst Doubles Immuneering Price Target Citing Initial Data Validation
↗
April 19, 2023
Via
Benzinga
Immuneering Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updates
March 01, 2024
From
Immuneering Corporation
Via
GlobeNewswire
Immuneering Receives FDA Fast Track Designation for IMM-1-104 in Pancreatic Cancer
February 20, 2024
From
Immuneering Corporation
Via
GlobeNewswire
3 Hidden-Gem Biotech Stocks Ready to Ride a Massive Market Wave
↗
February 14, 2024
Explore hidden-gem biotech stocks set for growth in a booming market. Uncover top picks ready to redefine healthcare innovation.
Via
InvestorPlace
Immuneering Announces Participation in February Investor Conferences
February 01, 2024
From
Immuneering Corporation
Via
GlobeNewswire
What 7 Analyst Ratings Have To Say About Immuneering
↗
April 19, 2023
Via
Benzinga
Immuneering Announces FDA Clearance of IND Application for Phase 1/2a Trial of IMM-6-415 to Treat Advanced Solid Tumors with RAF or RAS Mutations
December 12, 2023
From
Immuneering Corporation
Via
GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Intraday Session
↗
November 21, 2023
Via
Benzinga
Immuneering to Present at the 35th Annual Piper Sandler Healthcare Conference
November 20, 2023
From
Immuneering Corporation
Via
GlobeNewswire
Immuneering Reports Third Quarter 2023 Financial Results and Provides Business Updates
November 09, 2023
From
Immuneering Corporation
Via
GlobeNewswire
Immuneering Presents Preclinical Data Demonstrating Encouraging Anti-Tumor Activity for IMM-1-104 and IMM-6-415 at AACR-NCI-EORTC Conference
October 12, 2023
From
Immuneering Corporation
Via
GlobeNewswire
Immuneering to Present Preclinical Data on IMM-1-104 and IMM-6-415 at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
October 04, 2023
From
Immuneering Corporation
Via
GlobeNewswire
Immuneering to Present at the Morgan Stanley Healthcare Conference
September 06, 2023
From
Immuneering Corporation
Via
GlobeNewswire
Immuneering Reports Second Quarter 2023 Financial Results and Provides Business Updates
August 03, 2023
From
Immuneering Corporation
Via
GlobeNewswire
Immuneering Completes Dose Escalation in the IMM-1-104 Phase 1 Clinical Trial for RAS-Mutant, Advanced Solid Tumors
June 05, 2023
From
Immuneering Corporation
Via
GlobeNewswire
Immuneering to Present at the Jefferies Healthcare Conference
May 30, 2023
From
Immuneering Corporation
Via
GlobeNewswire
Immuneering Reports First Quarter 2023 Financial Results and Provides Business Updates
May 04, 2023
From
Immuneering Corporation
Via
GlobeNewswire
Immuneering Announces $30 Million Underwritten Offering
April 18, 2023
From
Immuneering Corporation
Via
GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For April 19, 2023
↗
April 19, 2023
Via
Benzinga
Immuneering Announces Positive Initial Phase 1 Pharmacokinetic, Pharmacodynamic and Safety Data for IMM-1-104 Universal-RAS Program; Accelerates Study Timeline
April 18, 2023
From
Immuneering Corporation
Via
GlobeNewswire
Immuneering to Present at the 22nd Annual Needham Virtual Healthcare Conference
April 12, 2023
From
Immuneering Corporation
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's Intraday Session
↗
April 07, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
↗
April 06, 2023
Via
Benzinga
Immuneering to Present Initial Phase 1 Pharmacokinetic, Pharmacodynamic Modeling and Safety Data for Universal-RAS Program IMM-1-104 at American Association for Cancer Research Annual Meeting 2023
April 05, 2023
- Investor call to be held at 9:00 a.m. ET on April 18, 2023 -
From
Immuneering Corporation
Via
GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For March 30, 2023
↗
March 30, 2023
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
